argenx Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
$374 million in fourth quarter and $1.2 billion in full year global net product salessBLA for VYVGART® Hytrulo for CIDP accepted for priority revi...
Source: businessinsider.com